Clover Health Investments Corp (NASDAQ: CLOV) announced that Chief Financial Officer Peter Kuipers stepped down from his position effective March 30, 2026. The Medicare-focused healthcare company stated that Kuipers' departure does not reflect any disagreement with the company on operational, policy or practice matters.

The board of directors appointed Clay Thornton, currently CFO of Clover's insurance plan, as interim CFO effective immediately. Kuipers will remain with the company in an advisory capacity through April 24, 2026 to facilitate the transition.

Thornton brings experience across Medicare Advantage, value-based care and healthcare finance. Prior to joining Clover, he held financial and strategic leadership roles within Medicare Advantage at Humana, along with positions in venture capital and private equity finance. He holds a bachelor's degree in finance and economics from the University of Kentucky and an MBA from the University of Louisville.

"I am honored to have served Clover and proud of what our team has accomplished during my tenure," Kuipers said in a statement. "Together, we built a strong financial and operating foundation for the company, with a focus on execution, operational efficiency, disciplined capital allocation, and long-term value creation."

CEO Andrew Toy said Kuipers "has been instrumental in helping Clover achieve sustainable profitability while achieving above market growth." Toy added that Thornton "is already deeply involved in the day to day finances of the business and knows both Medicare Advantage, and Clover's unique approach to it, very well."

The company reiterated its financial guidance for fiscal year 2026, which was updated in its February 26, 2026 earnings release.